Education
About Us
Working with TipRanks
Follow Us
Connie Matsui Insider Profile
4 Followers
Connie Matsui, Director at Halozyme, holds 50.00K shares in Sutro Biopharma (Ticker: STRO), holds 183.03K shares in Halozyme (Ticker: HALO), holds 56.67K shares in Artelo Biosciences (Ticker: ARTL). Most recently, Connie Matsui Bought ― shares of Sutro Biopharma on Oct 16, 2025 for an estimated value of $39.50K.
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
-17.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Connie Matsui holds in companies
Most Profitable Insider Trade
The most profitable trade made by Connie Matsui
Connie Matsui's Trading History
Halozyme
Dec 03, 2024
Director
Uninformative Sell
―
$12.27M
Sutro Biopharma
Oct 16, 2025
Director
Informative Buy
39.50K
$50.50K
Artelo Biosciences
May 04, 2020
Director
Informative Buy
50.00K
$237.43K
Biogen
―
EVP, Corp. Strategy and Comm.
―
$9.10M
List of latest transactions for each holding click on a transaction to see Connie Matsui's performance on stock
You May Also Like
Connie Matsui insider profile FAQ
What is the percentage of profitable transactions made by Connie Matsui?
The percentage of profitable transactions made by Connie Matsui is 40%.
What is the average return per transaction made by Connie Matsui?
The average return per transaction made by Connie Matsui is -17.30%.
What stocks does Connie Matsui hold?
Connie Matsui holds: HALO, STRO, ARTL, BIIB stocks.
What was Connie Matsui’s latest transaction?
Connie Matsui latest transaction was an Informative Buy of $39.50K.
What was Connie Matsui's most profitable transaction?
Connie Matsui’s most profitable transaction was an Informative Buy of STRO stock on October 16, 2025. The return on the trade was 14.70%.
What is Connie Matsui's role in Halozyme?
Connie Matsui's role in Halozyme is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.